CN103495231A - Intelligent drug release device - Google Patents

Intelligent drug release device Download PDF

Info

Publication number
CN103495231A
CN103495231A CN201310482868.5A CN201310482868A CN103495231A CN 103495231 A CN103495231 A CN 103495231A CN 201310482868 A CN201310482868 A CN 201310482868A CN 103495231 A CN103495231 A CN 103495231A
Authority
CN
China
Prior art keywords
module
blood glucose
food
ins
information
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310482868.5A
Other languages
Chinese (zh)
Inventor
李秀
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310482868.5A priority Critical patent/CN103495231A/en
Publication of CN103495231A publication Critical patent/CN103495231A/en
Pending legal-status Critical Current

Links

Images

Abstract

The invention discloses an intelligent drug release device which comprises a storage module, an input module, a calculation module and a drug release mechanism. The storage module is used for storing food varieties, food sugar indexes and the ratio of CHO/INS. The input module is used for inputting the food varieties and quantities. The calculation module is used for inquiring the corresponding food sugar indexes from the storage module according to the food varieties input by the input module, calculating the food quantities input by the input module and the food sugar indexes to obtain the sugar quantities of the input food, reading the ratio of CHO/INS from the storage module, and dividing the sugar quantities of the food by the ratio of CHO/INS to obtain the INS amount required to be output. The drug release mechanism is used for releasing the INS according to the INS amount calculated by the calculation module. By the utilization of the intelligent drug release device, the accuracy of administration dosage can be improved.

Description

The intellectual drug releasing device
Technical field
The present invention relates to the medical medicine infusion art, relate in particular to a kind of intellectual drug releasing device.
Background technology
At present, drug release device is widely applied in the middle of disease treatment.For example, having occurred that at present a kind of insulin medicament discharges pen, is exactly a kind of drug release device of pen type, wherein mainly comprises: syringe needle, insulin pen-cartridge, drug release mechanism etc.But, current drug release device only can discharge medicine in patient body, as injection, high-pressure injection etc., can't provide with the corresponding dose of the characteristic of discharged medicine and control function, its dose is mainly rule of thumb to be estimated to obtain by user, for the treating diabetes field, the treatment field of type i diabetes especially, existing this drug release device can't provide accurate drug dose, cause patient's glycemic control undesirable, the genesis that has accelerated complication.
Summary of the invention
In view of this, main purpose of the present invention is a kind of intellectual drug releasing device, to improve the degree of accuracy of dosage, thereby controls better patient's blood sugar level.
In order to realize the foregoing invention purpose, main technical schemes of the present invention is:
A kind of intellectual drug releasing device, this device comprises:
Memory module, for the ratio C HO/INS of storage food kind and sugary index and saccharide and insulin;
Input module, for kind and the quantity of inputting food;
Computing module, from sugary index corresponding to described memory module inquiry, utilize the size of food of described input module input and the sugary quantity that described sugary Index for Calculation obtains inputted food for the food species according to described input module input; Read CHO/INS from described memory module, the sugary quantity of described food, divided by CHO/INS, is obtained to the amount of insulin that will export;
Drug release mechanism, for the amount of insulin uelralante calculated according to described computing unit.
In a kind of preferred version, this intellectual drug releasing device further comprises the blood glucose module, for receiving blood glucose information, according to predetermined span, described blood glucose information is carried out to classification, and stores in described memory module.
In a kind of preferred version, this intellectual drug releasing device further comprises judge module, for the blood glucose information after the described classification to stored, is added up, and when the blood glucose information of specified level reaches predetermined quantity, triggers default respective operations.
In a kind of preferred version, described judge module specifically for: when other blood glucose information of hyperglycemia scope level reaches predetermined quantity, show corresponding warning information or the CHO/INS in described memory module reduced to a default unit value; When other blood glucose information of hypoglycemia scope level reaches predetermined quantity, show corresponding warning information or the CHO/INS in described memory module is improved to a default unit value.
In a kind of preferred version, described blood glucose information comprises the time;
Described judge module is specifically for residing period of time of determining blood glucose information according to default period division information, blood glucose information after classification in day part is added up, when other blood glucose information of hyperglycemia scope level reaches predetermined quantity, show that corresponding warning information or the CHO/INS that this period in memory module is corresponding reduce a default unit value; When other blood glucose information of hypoglycemia scope level reaches predetermined quantity, show that corresponding warning information or the CHO/INS that this period in memory module is corresponding improve a default unit value.
In a kind of preferred version, the sugary index information of the food in described memory module is pre-stored; Perhaps, this device further comprises the sugary index input module of food, for receiving the sugary index information of food of user's input, and is stored in described memory module.
In a kind of preferred version, this device can further comprise the blood sugar test prompting module, for judgement, after the insulin input, whether arrives the scheduled time, is to send alarm signal.
In a kind of preferred version, described device further comprises Man Machine Interface, for the information to described memory module, modifies.
In a kind of preferred version, between described drug release mechanism and described computing module, by wireless signal, communicate.
Compared with prior art, the present invention utilizes memory module storage food kind and sugary index thereof, and the ratio C HO/INS of saccharide and insulin, utilize kind and the quantity of input module input food, computing module is inquired about corresponding sugary index according to the food species of described input module input from described memory module, utilize the size of food of described input module input and the sugary quantity that described sugary Index for Calculation obtains inputted food, read CHO/INS from described memory module, by the sugary quantity of described food divided by CHO/INS, obtain the amount of insulin that will export, finally, the amount of insulin uelralante calculated according to described computing unit by drug release mechanism.Therefore, the food species that the present invention can will take according to the patient and quantity intelligence, accurately calculate the insulin dose of required input, improve the degree of accuracy of dosage, controlled better patient's blood sugar level, slowed down generation and the development of diabetic complication.
The accompanying drawing explanation
A kind of composition schematic diagram that Fig. 1 is intellectual drug releasing device of the present invention;
Another composition schematic diagram that Fig. 2 is intellectual drug releasing device of the present invention;
Another composition schematic diagram that Fig. 3 is intellectual drug releasing device of the present invention;
Another composition schematic diagram that Fig. 4 is intellectual drug releasing device of the present invention.
The specific embodiment
Below by specific embodiments and the drawings, the present invention is described in further details.
A kind of composition schematic diagram that Fig. 1 is intellectual drug releasing device of the present invention; Referring to Fig. 1, this intellectual drug releasing device 100 comprises:
Memory module 101, for the ratio C HO/INS of storage food kind and sugary index and saccharide and insulin.
Described CHO/INS is the CHO/INS corresponding with the user, each user's CHO/INS may be different, within the different time periods, same user's CHO/INS is also likely different, therefore the present invention also further comprises Man Machine Interface, modify for the CHO/INS to described memory module 101, can certainly modify to the sugary index of food.
Input module 102, for kind and the quantity of inputting food;
Described input module 102 can provide Man Machine Interface, and as devices such as display screen, keyboards, the user can pass through these Man Machine Interface input messages.
Computing module 103, from sugary index corresponding to described memory module 101 inquiry, utilize the size of food of described input module 102 inputs and the sugary quantity that described sugary Index for Calculation obtains inputted food for the food species according to described input module 102 inputs; Read CHO/INS from described memory module 101, the sugary quantity of described food, divided by CHO/INS, is obtained to the amount of insulin that will export;
For example, the sugary index of having stored steamed bread in described memory module 101 is 50%, if input module 102 inputs " steamed bread ", quantity is " 150 gram ", to inquire the sugary index that steamed bread is corresponding from memory module 101 be 50% to computing module 103, and the sugary quantity of current inputted steamed bread is 150 * 50%=75 gram, if user's CHO/INS is 15, needing the amount of insulin of output is 75 ÷ 15=5U, the unit that described U is insulin.
Drug release mechanism 104, for the amount of insulin uelralante calculated according to described computing unit.As this drug release mechanism 104 can be that insulin discharges pen or insulin discharges pump etc., described delivery mode can be for example injection system, can be also spray regime etc.This Fig. 1 be take injection system and is described as example, and comprising injection needle 105, drug release mechanism 104 can enter drug injection in patient body by this injection needle 105.If the amount of insulin 5U calculated as above-mentioned computing module 103,104 of this drug release mechanism are to the insulin that discharges 5U in patient body.Described drug release mechanism 104 can directly stick on patient's skin 110, or can be embedded under patient skin.Certainly, described injection needle can be also the injection device with long duct and syringe needle, syringe needle can be imbedded to the patient subcutaneous, drug release mechanism is worn on other positions (as being worn on loins) of patient body, and drug release mechanism is injected medicine in patient body by conduit and syringe needle.
Another composition schematic diagram that Fig. 2 is intellectual drug releasing device of the present invention; Referring to Fig. 2, this intellectual drug releasing device further comprises blood glucose module 106, for receiving blood glucose information, according to predetermined span, described blood glucose information is carried out to classification, and stores in described memory module 101.
In a kind of preferred embodiment, described blood glucose module 106 can comprise for the blood sugar test module of test organism blood glucose value and classification computing module.
Described blood sugar test module is for detection of the blood glucose value of organism, and generation can be carried out the blood glucose level data of communication transfer.Organism of the present invention is human body, can be also animal body, and the human body of take herein describes as example.The concentration value that described blood glucose value is glucose in blood, the sample that described blood sugar test module detects can be blood sample, by the blood glucose sample is detected and draws blood glucose value, the concrete blood sugar test technology adopted can be industry blood sugar test product technology commonly used, such as electrochemical process test and luminous reflectance technical testing etc.; The physiologically sample that perhaps described blood sugar test module also can directly or indirectly reflect blood glucose value by detecting other, and calculate blood glucose value, can be for example to calculate the detector of blood glucose value by detecting body fluid, can be also by skin or eyes are carried out to the detector that spectrum analysis calculating obtains blood glucose value.The blood glucose that described blood sugar test module detects can be that single-point is discrete, can be also dynamically continuous.As for the blood glucose value in concrete how detection of biological body, not emphasis of the present invention, can be with reference to prior art, this paper repeats no more.Described classification computing module is for carrying out classification calculating according to predetermined span by the detected blood glucose value of described blood sugar test module, for example described span can be divided into Three Estate: the hyperglycemia scope, the euglycemia scope, the hypoglycemia scope, described range of blood sugar also can adopt according to the difference of time period different value ranges, for example the hyperglycemia scope of period can be to be greater than 6.2 before the meal, the hyperglycemia scope of period can be to be greater than 8.6 after the meal, and described classification computing module can provide Man Machine Interface, by this Man Machine Interface, described range of blood sugar can be arranged by the user.
In another kind of preferred embodiment, described blood glucose module 106 also can comprise blood glucose input module and classification computing module.
Described blood glucose input module can provide Man Machine Interface or the communication interface with extraneous blood glucose monitoring system is provided, the user can input blood glucose information (comprising blood glucose value, testing time etc.) by hand by described Man Machine Interface, perhaps described and communication interface extraneous blood glucose monitoring system can receive the detected blood glucose information of extraneous blood glucose monitoring system, and this communication interface can be that wired communication interface can be also wireless communication interface.Described classification computing module carries out classification calculating for the blood glucose value described blood glucose input module received according to predetermined span, and concrete classification account form as mentioned above.
As shown in Figure 2, in a kind of preferred embodiment, described intellectual drug releasing device further comprises judge module 107, for the blood glucose information after the described classification to stored, is added up, when the blood glucose information of specified level reaches predetermined quantity, trigger default respective operations.
In a kind of preferred embodiment, described judge module 107 specifically for: when other blood glucose information of hyperglycemia scope level reaches predetermined quantity, show corresponding warning information or the CHO/INS in described memory module 101 reduced to a default unit value; When other blood glucose information of hypoglycemia scope level reaches predetermined quantity, show corresponding warning information or the CHO/INS in described memory module 101 is improved to a default unit value.
For example, reach predetermined quantity (as over three times), display alarm information when other blood glucose information of hyperglycemia scope level, for example show " CHO/INS is too high; suggestion reduces the value of CHO/INS ", or automatically described CHO/INS is reduced to a default unit value, for example reduce by 1.If the blood glucose information of the hypoglycemia access level of this period reaches predetermined quantity (as three times), show " CHO/INS is too low, and suggestion increases the value of CHO/INS ", or automatically described CHO/INS is increased to a default unit value, for example increase by 1.
In a kind of preferred embodiment, described blood glucose information comprises the time; Described judge module 107 is specifically for residing period of time of determining blood glucose information according to default period division information, blood glucose information after classification in day part is added up, when other blood glucose information of hyperglycemia scope level reaches predetermined quantity, show that corresponding warning information or the CHO/INS that this period in memory module 101 is corresponding reduce a default unit value; When other blood glucose information of hypoglycemia scope level reaches predetermined quantity, show that corresponding warning information or the CHO/INS that this period in memory module 101 is corresponding improve a default unit value.
For example, described period division information comprises early, middle and late, four periods of night, and right CHO/INS of each period is likely different.Suppose that early the CHO/INS of period is 15, if the blood glucose information of the hyperglycemia access level of this period reaches predetermined quantity (as three times), show " CHO/INS is too high; suggestion reduces the value of CHO/INS ", or automatically described CHO/INS is reduced to a default unit value, for example reduce by 1, become 14.If the blood glucose information of the hypoglycemia access level of this period reaches predetermined quantity (as three times), show " CHO/INS is too low, and suggestion increases the value of CHO/INS ", or automatically described CHO/INS is increased to a default unit value, for example increase by 1, become 16.
The sugary index information of food in described memory module 101 is pre-stored; Perhaps, as shown in Figure 3, this device further comprises the sugary index input module 108 of food, for receiving the sugary index information of food of user's input, and is stored in described memory module 101.
Referring to Fig. 3, in a kind of preferred embodiment, intellectual drug releasing device of the present invention also further comprises blood sugar test prompting module 109, (this scheduled time can be arranged by the user by Man Machine Interface whether to arrive the scheduled time for judgement after the insulin input, and be stored in memory module 101), be to send alarm signal (the random time reminding user that for example can be arranged in 30 minutes to 4 hours is after the meal surveyed blood glucose).
In a kind of preferred embodiment,, described device can further include Man Machine Interface 111, for the information to described memory module 101, modifies.
In above-described embodiment, between described drug release mechanism 104 and computing module 103, can be wire communication, can be also radio communication.As Fig. 4 is that another of intellectual drug releasing device of the present invention forms schematic diagram, in the present embodiment, between described drug release mechanism 104 and other module, it is Split type structure, described drug release mechanism 104 directly sticks on patient's skin 110, perhaps can be embedded under patient skin, between described drug release mechanism 104 and described computing module 103, by wireless signal, communicate, facilitate persistence to injectable drug in patient body, as this drug release mechanism 104 can be a kind of syringe pump (as insulin infusion pump etc.) that can the sustained release medicine, other module can be integrated in a module 401, with described drug release mechanism 104, separates, and facilitates the user to carry and holds and take, and needn't stick on patient skin or be embedded under patient skin.This separate mode can make the patient after the syringe pump of having worn the sustained release medicine, both can realize the function of intelligence computation drug dose of the present invention and the various embodiments described above, does not affect again patient's freedom of action, facilitates the patient to carry described syringe pump.
In a preferred embodiment of the present invention, described intellectual drug releasing device is that insulin medicament discharges pen.
In another kind of preferred embodiment of the present invention, described intellectual drug releasing device is that insulin medicament discharges pump.
The above; be only the present invention's specific embodiment preferably, but protection scope of the present invention is not limited to this, anyly is familiar with the people of this technology in the disclosed technical scope of the present invention; the variation that can expect easily or replacement, within all should being encompassed in protection scope of the present invention.

Claims (9)

1. an intellectual drug releasing device, is characterized in that, this device comprises:
Memory module, for the ratio C HO/INS of storage food kind and sugary index and saccharide and insulin;
Input module, for kind and the quantity of inputting food;
Computing module, from sugary index corresponding to described memory module inquiry, utilize the size of food of described input module input and the sugary quantity that described sugary Index for Calculation obtains inputted food for the food species according to described input module input; Read CHO/INS from described memory module, the sugary quantity of described food, divided by CHO/INS, is obtained to the amount of insulin that will export;
Drug release mechanism, for the amount of insulin uelralante calculated according to described computing unit.
2. intellectual drug releasing device according to claim 1, it is characterized in that, this intellectual drug releasing device further comprises the blood glucose module, for receiving blood glucose information, according to predetermined span, described blood glucose information is carried out to classification, and store in described memory module.
3. intellectual drug releasing device according to claim 2, it is characterized in that, this intellectual drug releasing device further comprises judge module, for the blood glucose information to after stored described classification, added up, when the blood glucose information of specified level reaches predetermined quantity, trigger default respective operations.
4. intellectual drug releasing device according to claim 3, it is characterized in that, described judge module specifically for: when other blood glucose information of hyperglycemia scope level reaches predetermined quantity, show corresponding warning information or the CHO/INS in described memory module reduced to a default unit value; When other blood glucose information of hypoglycemia scope level reaches predetermined quantity, show corresponding warning information or the CHO/INS in described memory module is improved to a default unit value.
5. intellectual drug releasing device according to claim 4, is characterized in that, described blood glucose information comprises the time;
Described judge module is specifically for residing period of time of determining blood glucose information according to default period division information, blood glucose information after classification in day part is added up, when other blood glucose information of hyperglycemia scope level reaches predetermined quantity, show that corresponding warning information or the CHO/INS that this period in memory module is corresponding reduce a default unit value; When other blood glucose information of hypoglycemia scope level reaches predetermined quantity, show that corresponding warning information or the CHO/INS that this period in memory module is corresponding improve a default unit value.
6. intellectual drug releasing device according to claim 1, is characterized in that,
The sugary index information of food in described memory module is pre-stored;
Perhaps, this device further comprises the sugary index input module of food, for receiving the sugary index information of food of user's input, and is stored in described memory module.
7. intellectual drug releasing device according to claim 1, is characterized in that, further comprises the blood sugar test prompting module, for judgement, after the insulin input, whether arrives the scheduled time, is to send alarm signal.
8. intellectual drug releasing device according to claim 1, is characterized in that, described device further comprises Man Machine Interface, for the information to described memory module, modifies.
9. intellectual drug releasing device according to claim 1, is characterized in that, between described drug release mechanism and described computing module, by wireless signal, communicates.
CN201310482868.5A 2013-10-16 2013-10-16 Intelligent drug release device Pending CN103495231A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310482868.5A CN103495231A (en) 2013-10-16 2013-10-16 Intelligent drug release device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310482868.5A CN103495231A (en) 2013-10-16 2013-10-16 Intelligent drug release device

Publications (1)

Publication Number Publication Date
CN103495231A true CN103495231A (en) 2014-01-08

Family

ID=49860544

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310482868.5A Pending CN103495231A (en) 2013-10-16 2013-10-16 Intelligent drug release device

Country Status (1)

Country Link
CN (1) CN103495231A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103118468A (en) * 2013-02-19 2013-05-22 广州从兴电子开发有限公司 Method and device for remotely controlling LED streetlamp
CN107050578A (en) * 2017-05-04 2017-08-18 梁曦 A kind of medicine automated injection device

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101477128A (en) * 2009-01-23 2009-07-08 李秀 Blood sugar test system
CN101789229A (en) * 2009-01-23 2010-07-28 李秀 Health information display and control device and method, corresponding equipment and reagent carrier
CN101785702A (en) * 2009-01-23 2010-07-28 李秀 Health information system, method, corresponding device, equipment and reagent carrier
CN101785701A (en) * 2009-01-23 2010-07-28 李秀 Device and method for processing information, equipment and reagent carrier
WO2010083766A1 (en) * 2009-01-23 2010-07-29 理康互联科技(北京)有限公司 Health information system, method and corresponding apparatus, device and reagent carrier
CN102000372A (en) * 2010-12-09 2011-04-06 江苏华阳电器有限公司 Intelligent insulin pump system
CN102028542A (en) * 2009-09-29 2011-04-27 李秀 Information acquisition display system, method, device, medium, equipment and terminal
CN102048522A (en) * 2009-10-30 2011-05-11 李秀 Monitoring prompt device and method and corresponding device
CN102573949A (en) * 2009-09-02 2012-07-11 贝克顿·迪金森公司 Flexible and conformal patch pump
CN102802522A (en) * 2010-02-25 2012-11-28 生命扫描苏格兰有限公司 Analyte testing method and system with safety warnings for insulin dosing
CN103336853A (en) * 2008-04-04 2013-10-02 海吉雅有限公司 System for optimizing a patient's insulin dosage regimen

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103336853A (en) * 2008-04-04 2013-10-02 海吉雅有限公司 System for optimizing a patient's insulin dosage regimen
CN101477128A (en) * 2009-01-23 2009-07-08 李秀 Blood sugar test system
CN101789229A (en) * 2009-01-23 2010-07-28 李秀 Health information display and control device and method, corresponding equipment and reagent carrier
CN101785702A (en) * 2009-01-23 2010-07-28 李秀 Health information system, method, corresponding device, equipment and reagent carrier
CN101785701A (en) * 2009-01-23 2010-07-28 李秀 Device and method for processing information, equipment and reagent carrier
WO2010083766A1 (en) * 2009-01-23 2010-07-29 理康互联科技(北京)有限公司 Health information system, method and corresponding apparatus, device and reagent carrier
CN102573949A (en) * 2009-09-02 2012-07-11 贝克顿·迪金森公司 Flexible and conformal patch pump
CN102028542A (en) * 2009-09-29 2011-04-27 李秀 Information acquisition display system, method, device, medium, equipment and terminal
CN102048522A (en) * 2009-10-30 2011-05-11 李秀 Monitoring prompt device and method and corresponding device
CN102802522A (en) * 2010-02-25 2012-11-28 生命扫描苏格兰有限公司 Analyte testing method and system with safety warnings for insulin dosing
CN102000372A (en) * 2010-12-09 2011-04-06 江苏华阳电器有限公司 Intelligent insulin pump system

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103118468A (en) * 2013-02-19 2013-05-22 广州从兴电子开发有限公司 Method and device for remotely controlling LED streetlamp
CN107050578A (en) * 2017-05-04 2017-08-18 梁曦 A kind of medicine automated injection device

Similar Documents

Publication Publication Date Title
US11224362B2 (en) Method and/or system for determining blood glucose reference sample times
CN107073207B (en) Continuous glucose monitoring injection device
US9619625B2 (en) System for optimizing a patient's drug dosage regimen over time
US11116901B2 (en) Automatic detection of un-bolused meals
US10293109B2 (en) Adaptive system for optimizing a drug dosage regimen over time
WO2019118537A1 (en) Therapy management systems, methods, and devices
US8439897B2 (en) Assessing residual insulin time
CN106659843A (en) Glucagon administration system and methods
US11017891B2 (en) Titration of basal insulin with two modes
WO2013186104A1 (en) Medical device and method for displaying medical data by a medical device
CN102048522A (en) Monitoring prompt device and method and corresponding device
CN104027867A (en) Portable intelligent dual-function diabetes treatment pump
CN103495231A (en) Intelligent drug release device
CN203577053U (en) Intelligent medicine releasing device
CN103495232A (en) Intelligent drug release device
CN203577072U (en) Medicine releasing device
US20220096749A1 (en) Drug delivery device with integrated optical-based glucose monitor
US20230248909A1 (en) Techniques for determining medication correction factors in automatic medication delivery systems
EP4261835A1 (en) System and method for creating or adjusting manual basal profiles
WO2024081559A1 (en) System and method for determining the effect of ingestion of meals of varying carbohydrate content
WO2019118538A1 (en) Devices, systems, and methods for estimating active medication from injections
WO2019118541A1 (en) User interface for diabetes management systems and devices
CN103550842A (en) Insulin release device

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140108